Science Explorer Back to mapMap

Most cited papers from Medisch Centrum Haaglanden

What are the most cited papers from Medisch Centrum Haaglanden?

The most cited paper from Medisch Centrum Haaglanden is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke" (6,707) and "Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research" (2,659).

Showing 50 of 60 papers. Every paper with more than 298 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
2 A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke Olvert A. Berkhemer et al. · New England Journal of Medicine Open access 17 Dec 2014 6,707
3 Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research Andrew I.R. Maas et al. · The Lancet Neurology Open access335 authors 6 Nov 2017 2,659
4 EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood Michael Weller et al. · Nature Reviews Clinical Oncology ReviewOpen access 8 Dec 2020 2,063
5 Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Mila Donker et al. · The Lancet Oncology Open access 15 Oct 2014 1,891
6 A Comparison of Suture Repair with Mesh Repair for Incisional Hernia Roland W. Luijendijk, Wim C.J. Hop, Monique Petrousjka van den Tol et al. · New England Journal of Medicine 10 Aug 2000 1,876
7 Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951 Martin J. van den Bent, Alba Ariela Brandes, Martin Taphoorn et al. · Journal of Clinical Oncology Open access 16 Oct 2012 1,236
8 Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions Patrick Yung Wen et al. · Neuro-Oncology Open access 20 Apr 2020 1,183
9 European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas Michael Weller et al. · The Lancet Oncology Open access 5 May 2017 1,122
10 Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Roger Stupp et al. · The Lancet Oncology Open access 19 Aug 2014 1,053
11 Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer Philip M. Poortmans et al. · New England Journal of Medicine Open access 22 Jul 2015 1,033
12 Lomustine and Bevacizumab in Progressive Glioblastoma Wolfgang Wick et al. · New England Journal of Medicine Open access 15 Nov 2017 1,008
13 CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19—Definition and Evaluation Mathias Prokop, Wouter M. van Everdingen, Tjalco van Rees Vellinga et al. · Radiology Open access 27 Apr 2020 964
14 Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial Jan Bolinder, Ramiro Antuna, Petronella H.L.M. Geelhoed-Duijvestijn et al. · The Lancet 13 Sep 2016 903
15 Surgery versus Prolonged Conservative Treatment for Sciatica Wilco C. Peul, Hans C. van Houwelingen, Wilbert B. van den Hout et al. · New England Journal of Medicine Open access 30 May 2007 870
16 Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial Evelien de Jong et al. · The Lancet Infectious Diseases Open access 2 Mar 2016 847
17 Decontamination of the Digestive Tract and Oropharynx in ICU Patients Anne Marie G. A. de Smet et al. · New England Journal of Medicine Open access 31 Dec 2008 830
18 Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial Corine M. Koopmans et al. · The Lancet 4 Aug 2009 802
19 Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis Emelie C Schuts, Marlies Hulscher, Johan Willem Mouton et al. · The Lancet Infectious Diseases Review 2 Mar 2016 782
20 Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial Walter Taal et al. · The Lancet Oncology 14 Jul 2014 768
21 Cognitive deficits in adult patients with brain tumours Martin JB Taphoorn, Martin Klein · The Lancet Neurology Open access 21 Feb 2004 760
22 A prospective validation of the HEART score for chest pain patients at the emergency department Barbra E. Backus, A. Jacob Six, Johannes C. Kelder et al. · International Journal of Cardiology Open access 7 Mar 2013 590
23 Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034 Martin J. van den Bent, Alba Ariela Brandes, R. Rampling et al. · Journal of Clinical Oncology Open access 9 Feb 2009 578
24 Glioma Michael Weller, Patrick Yung Wen, Susan Marina Chang et al. · Nature Reviews Disease Primers Review 9 May 2024 577
25 Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion Lucianne C.M. Langezaal et al. · New England Journal of Medicine Open access 19 May 2021 575
26 Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study Tom van der Hulle et al. · The Lancet 23 May 2017 552
27 Coronary Angiography after Cardiac Arrest without ST-Segment Elevation Jorrit S. Lemkes et al. · New England Journal of Medicine Open access 18 Mar 2019 548
28 Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study Ewout Willem Steyerberg et al. · The Lancet Neurology Open access256 authors 12 Sep 2019 513
29 International consensus conference on stool banking for faecal microbiota transplantation in clinical practice Giovanni Cammarota et al. · Gut Open access 28 Sep 2019 510
30 Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study Brigitta G. Baumert et al. · The Lancet Oncology Open access 29 Sep 2016 504
31 Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial Jeanin Elise van Hooft, Willem Adrianus Bemelman, Bas Oldenburg et al. · The Lancet Oncology Open access 16 Mar 2011 473
32 Radiotherapy during pregnancy: fact and fiction Henk B. Kal, Henk Struikmans · The Lancet Oncology 28 Apr 2005 448
33 DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis Linda M. Henricks et al. · The Lancet Oncology Open access 19 Oct 2018 442
34 Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years Janet T. Powell et al. · British journal of surgery ReviewOpen access714 authors Feb 2017 432
35 Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology Khê Hoang‐Xuan, Eric M. Bessell, Jacoline E. C. Bromberg et al. · The Lancet Oncology Open access 29 Jun 2015 427
36 Fecal Microbiota Transplantation in Neurological Disorders Karuna E.W. Vendrik, Rogier E. Ooijevaar, Pieter R. C. de Jong et al. · Frontiers in Cellular and Infection Microbiology Open access 24 Mar 2020 415
37 An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients Martin J.B. Taphoorn, Lily Claassens, Neil K. Aaronson et al. · European Journal of Cancer 23 Feb 2010 404
38 Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod Manon van Seters, Marc van Beurden, Fiebo J.W. ten Kate et al. · New England Journal of Medicine Open access 2 Apr 2008 399
39 Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial Cornelis A. J. van Beers, J. Hans DeVries, Susanne J. Kleijer et al. · The Lancet Diabetes & Endocrinology 15 Sep 2016 390
40 Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial Sanne A. L. Bartels et al. · Journal of Clinical Oncology Open access 16 Nov 2022 389
41 Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study Wendy Zondag, Inge C. M. Mos, Dina Creemers-Schild et al. · Journal of Thrombosis and Haemostasis Open access 6 Jun 2011 381
42 Surgery versus conservative management of sciatica due to a lumbar herniated disc: a systematic review Wilco C. H. Jacobs, Maurits W. van Tulder, Mark P. Arts et al. · European Spine Journal ReviewOpen access 14 Oct 2010 378
43 Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome Johannes G. Dauwerse, Jill Dixon, Saskia Seland et al. · Nature Genetics 5 Dec 2010 378
44 Meningioma Christine Marosi, Marco Ronald Hassler, Karl Rössler et al. · Critical Reviews in Oncology/Hematology 15 Mar 2008 377
45 Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants Ying Jin et al. · Nature Genetics Open access 10 Oct 2016 365
46 Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: Results of a national prospective study Yaël A de Man, Johanna M. W. Hazes, Hugo van der Heide et al. · Arthritis & Rheumatism 29 Oct 2009 362
47 Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism Liselotte M. van der Pol et al. · New England Journal of Medicine Open access 20 Mar 2019 358
48 Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands Matthijs Oudkerk, Harry Roger Buller, Dirkjan Kuijpers et al. · Radiology Open access 23 Apr 2020 357
49 Advances in local therapy for glioblastoma — taking the fight to the tumour Thomas S. van Solinge, Lisa Nieland, Ennio Antonio Chiocca et al. · Nature Reviews Neurology ReviewOpen access 11 Mar 2022 356
50 Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up Berit Jordan, Anita Margulies, Fátima Cardoso et al. · Annals of Oncology Open access 30 Jul 2020 346

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.